---
title: "Steris (STE) Receives a Buy from KeyBanc"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296080360.md"
description: "KeyBanc analyst Brett Fishbin maintained a Buy rating on Steris (STE) with a price target of $269.00. This follows Piper Sandler's Buy rating from August 7, while Needham held a Hold rating on August 6."
datetime: "2026-08-17T08:59:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296080360.md)
  - [en](https://longbridge.com/en/news/296080360.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296080360.md)
generator: "portal-rs"
---

# Steris (STE) Receives a Buy from KeyBanc

In a report released today, Brett Fishbin from KeyBanc maintained a Buy rating on Steris, with a price target of $269.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Fishbin covers the Healthcare sector, focusing on stocks such as Resmed, Cooper Co, and Integer Holdings. According to TipRanks, Fishbin has an average return of 0.0% and a 49.33% success rate on recommended stocks. 

In addition to KeyBanc, Steris also received a Buy from Piper Sandler’s Jason Bednar in a report issued on August 7. However, on August 6, Needham maintained a Hold rating on Steris (NYSE: STE).

### Related Stocks

- [STE.US](https://longbridge.com/en/quote/STE.US.md)
- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)
- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)

## Related News & Research

- [STERIS Stock Outlook: Is Wall Street Bullish or Bearish?](https://longbridge.com/en/news/297032161.md)
- [STERIS (STE) Could Be 10% Undervalued Following Strong Results And $600 Million Expansion](https://longbridge.com/en/news/295739510.md)
- [Alliance Global Partners Reaffirms Their Buy Rating on Pelthos Therapeutics (PTHS)](https://longbridge.com/en/news/296781912.md)
- [Freeport-McMoRan (FCX): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/296794439.md)
- [Maxim Group Reaffirms Their Buy Rating on Our Bond Inc (OBAI)](https://longbridge.com/en/news/296798454.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**